These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19817485)

  • 1. Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics.
    Butler GS; Overall CM
    Biochemistry; 2009 Nov; 48(46):10830-45. PubMed ID: 19817485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase proteomics: substrates, targets, and therapy.
    Morrison CJ; Butler GS; Rodríguez D; Overall CM
    Curr Opin Cell Biol; 2009 Oct; 21(5):645-53. PubMed ID: 19616423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors.
    Overall CM; Tam EM; Kappelhoff R; Connor A; Ewart T; Morrison CJ; Puente X; López-Otín C; Seth A
    Biol Chem; 2004 Jun; 385(6):493-504. PubMed ID: 15255181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidimensional degradomics identifies systemic autoantigens and intracellular matrix proteins as novel gelatinase B/MMP-9 substrates.
    Cauwe B; Martens E; Proost P; Opdenakker G
    Integr Biol (Camb); 2009 Jun; 1(5-6):404-26. PubMed ID: 20023747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease proteomics: revealing protease in vivo functions using systems biology approaches.
    Doucet A; Overall CM
    Mol Aspects Med; 2008 Oct; 29(5):339-58. PubMed ID: 18571712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases.
    Cauwe B; Opdenakker G
    Crit Rev Biochem Mol Biol; 2010 Oct; 45(5):351-423. PubMed ID: 20812779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane protease degradomics: proteomic identification and quantification of cell surface protease substrates.
    Butler GS; Dean RA; Smith D; Overall CM
    Methods Mol Biol; 2009; 528():159-76. PubMed ID: 19153692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics.
    Rodríguez D; Morrison CJ; Overall CM
    Biochim Biophys Acta; 2010 Jan; 1803(1):39-54. PubMed ID: 19800373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer.
    Overall CM; Dean RA
    Cancer Metastasis Rev; 2006 Mar; 25(1):69-75. PubMed ID: 16680573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MS-driven protease substrate degradomics.
    Impens F; Colaert N; Helsens K; Plasman K; Van Damme P; Vandekerckhove J; Gevaert K
    Proteomics; 2010 Mar; 10(6):1284-96. PubMed ID: 20058249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics.
    Overall CM; McQuibban GA; Clark-Lewis I
    Biol Chem; 2002; 383(7-8):1059-66. PubMed ID: 12437088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple roles of matrix metalloproteinases during apoptosis.
    Mannello F; Luchetti F; Falcieri E; Papa S
    Apoptosis; 2005 Jan; 10(1):19-24. PubMed ID: 15711919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic approaches to uncover MMP function.
    Schlage P; auf dem Keller U
    Matrix Biol; 2015; 44-46():232-8. PubMed ID: 25603365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-Resolved Analysis of Matrix Metalloproteinase Substrates in Complex Samples.
    Schlage P; Egli FE; Auf dem Keller U
    Methods Mol Biol; 2017; 1579():185-198. PubMed ID: 28299737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N- and C-terminal degradomics: new approaches to reveal biological roles for plant proteases from substrate identification.
    Huesgen PF; Overall CM
    Physiol Plant; 2012 May; 145(1):5-17. PubMed ID: 22023699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.
    Hu J; Van den Steen PE; Sang QX; Opdenakker G
    Nat Rev Drug Discov; 2007 Jun; 6(6):480-98. PubMed ID: 17541420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic profiling of proteases: tools for granzyme degradomics.
    van Domselaar R; de Poot SA; Bovenschen N
    Expert Rev Proteomics; 2010 Jun; 7(3):347-59. PubMed ID: 20536307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiphasic roles for matrix metalloproteinases after stroke.
    Rosell A; Lo EH
    Curr Opin Pharmacol; 2008 Feb; 8(1):82-9. PubMed ID: 18226583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases and vascular endothelium-mononuclear cell close encounters.
    Lessner SM; Galis ZS
    Trends Cardiovasc Med; 2004 Apr; 14(3):105-11. PubMed ID: 15121158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Matrix metalloproteinases in the central nervous system: clinical significance and therapeutic prospects].
    Sulik A; Ołdak E
    Pol Merkur Lekarski; 2008 Mar; 24(141):278-80. PubMed ID: 18634301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.